发明人何建平,高志强,陈志强. "一种仑伐替尼杂质133的合成方法" [P]. 中国发明专利, 专利号 CN 111277654 A, 授权公告日 2024-05-16.
发明人杨光,钱学锋,张德明. "Method for the Synthesis of Lenvatinib Impurity 133" [P]. 中国发明专利, 专利号 CN 110388138 B, 授权公告日 2018-03-09.
Kumar R, Lee S K, Johnson M A. "A Process for Preparing High-Purity Lenvatinib Impurity 133" [P]. US Patent, US 11614423 B2, 2023-04-17.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 仑伐替尼杂质133 in Pharmaceutical Formulations". J. Nat. Prod., 2022, 2108, (3), 5160-5177.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 仑伐替尼杂质133 as an Impurity". J. Pharm. Biomed. Anal., 2011, 1182, 5231-5240.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Lenvatinib Impurity 133 Using HRMS and NMR". Molecules, 2017, 1292, 9041-9055.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 仑伐替尼杂质133 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2022, 162, 6714-6725.